CBU
AZN icon

CIBC Bank USA’s AstraZeneca AZN Stock Holding History

CIBC Bank USA’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$227K Buy
+2,272
New +$214K 0.03% 255
2014
Q4 		– Sell
-3,056
Closed -$219K – 294
2014
Q3 		$219K Sell
3,056
-300
-9% -$22K 0.04% 267
2014
Q2 		$249K Buy
3,356
+131
+4% +$9.47K 0.05% 253
2014
Q1 		$209K Buy
+3,225
New +$208K 0.04% 294

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CIBC Bank USA's AZN Position: Q4 2019 in Review

CIBC Bank USA opened a new position in AstraZeneca (AZN) in Q4 2019: 2,272 shares worth $227K. The stake represents 0.03% of the portfolio and ranks #255 among its holdings. This is a return to the name: CIBC Bank USA previously reported a position in AZN as recently as Q3 2014.

CIBC Bank USA first reported a position in AZN in Q1 2014 and has held it in 4 quarters since. The position peaked at $249K in Q2 2014. 634 funds tracked by Wall St. Rank hold AZN as of Q4 2019.

  • CIBC Bank USA held 2,272 shares of AstraZeneca worth $227K as of Q4 2019.
  • AstraZeneca was a new CIBC Bank USA position in Q4 2019.
  • AstraZeneca made up 0.03% of CIBC Bank USA's portfolio in Q4 2019, its #255 holding.
  • CIBC Bank USA first reported a position in AstraZeneca in Q1 2014 and has held it in 4 quarters since.
  • CIBC Bank USA's AstraZeneca position peaked at $249K in Q2 2014.
  • 634 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.